Hamburg and Jülich, Germany 1/5/12—Eppendorf has announced the acquisition of DASGIP, which develops and manufactures parallel bioreactor systems and software. Financial terms were not disclosed. “DASGIP’s high-quality parallel bioreactors and software solutions nicely complement the current offering of our New Brunswick product lines,” stated Eppendorf CEO Dirk Ehlers. “They allow us to forge a comprehensive […]
San Diego, CA 1/3/12—Scientific enterprise R&D software firm Accelrys has purchased VelQuest for $35 million in cash. VelQuest provides paperless lab execution systems that support GMP for industries regulated by the FDA. Accelrys stated that the acquisition extends its software offerings into downstream pharmaceutical development QA/QC. “VelQuest’s strong products and proven domain expertise in compliance-intensive […]
Hillsboro, OR 1/9/12—FEI, a provider of imaging and analysis systems, has acquired ASPEX for $30.5 million. ASPEX supplies rugged scanning electron microscopes (SEMs) and related services for environmentally demanding military, industrial and factory floor applications. ASPEX generated sales of $10.0 million for the fiscal year ending June 30, 2011, and was profitable. The company’s sales […]
To say that 2011 was a good year would be an understatement. Somewhat unexpectedly, 2011 results were much better than we could have hoped, given the strong rebound in 2010. So now is the time to look ahead to the coming year and the prospects for the analytical and life science instrument industry. Based on […]
Each year since 2005, IBO has selected a firm from our industry as “company of the year.” This designation is based on IBO’s recognition that the selected analytical instrument maker has accomplished significant technical, operational and financial achievements during that year. Such achievements are measured by financial performance, market leadership, product introductions and key strategic […]
Global growth is slowing, according to the International Monetary Fund’s (IMF) World Economic Outlook, released in September 2011. The IMF expected global economic growth to be 4% through 2012, after 2010 growth of more than 5%, and now plans to lower that prediction. In November 2011, the Organization for Economic Co-operation and Development predicted global […]
Pharmaceutical and Biotechnology EvaluatePharma forecast that R&D spending by pharmaceutical companies will rise 1.0% this year to $134 billion, according to a June 2011 report. From now until 2016, R&D spending by drug companies is expected to grow an average of 2.5% annually to total $147 billion. EvaluatePharma forecasted prescription drug revenues to have a […]
The lab equipment market, as defined by IBO, consists of eight categories of techniques. The overall market totaled nearly $2.5 billion in 2011. With a 2012 growth rate of more than 4%, the market is expected to increase by $100 million by the end of 2012. While laboratory equipment of various types is found in […]
The general analytical techniques (GAT) section of the analytical instrument market is a collection of vary basic laboratory instruments: electrochemistry systems, laboratory balances, radioactivity instruments, dissolution testing equipment, and continuous flow and discrete analyzers. Although these technologies are fundamentally different from each other, they share similar market characteristics. These instruments are primarily low-end technologies, with […]
Total market demand for materials characterization instruments reached $2.18 billion in 2011 and is forecast to be $2.29 billion in 2012, representing growth of 5.2%. These instruments characterize the physical properties of a wide variety of materials. The different technology segments are organized by the specific kind of measurements being made or the specific sample […]
Pay Invoice
Latest Blogs
-
LAUDA: Temperature Control Innovation
December 10, 2024 4:11 pm
-
Perseverance Forecasted for the Pharmaceutical Market for Analytical and Scientific Instrumentation
October 24, 2024 5:17 pm
-
M&A Activity in the Analytical Instrumentation and Lab Tools Market. 2021-2023
September 30, 2024 1:32 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
